BACKGROUND: Clinical practice guidelines recommend estimation of glomerular filtration rate (eGFR) using validated equations based on serum creatinine (eGFRcr), cystatin C (eGFRcys), or both (eGFRcr-cys). However, when compared with the measured GFR (mGFR), only eGFRcr-cys meets recommended performance standards. Our goal was to develop a more accurate eGFR method using a panel of metabolites without creatinine, cystatin C, or demographic variables. METHODS: An ultra-performance liquid chromatography-tandem mass spectrometry assay for acetylthreonine, phenylacetylglutamine, pseudouridine, and tryptophan was developed, and a 20-day, multiinstrument analytical validation was conducted. The assay was tested in 2424 participants with mGFR data from 4 independent research studies. A new GFR equation (eGFRmet) was developed in a random subset (n = 1615) and evaluated in the remaining participants (n = 809). Performance was assessed as the frequency of large errors [estimates that differed from mGFR by at least 30% (1 - P30); goal <10%]. RESULTS: The assay had a mean imprecision (≤10% intraassay, ≤6.9% interassay), linearity over the quantitative range (r 2 > 0.98), and analyte recovery (98.5%-113%). There was no carryover, no interferences observed, and analyte stability was established. In addition, 1 - P30 in the validation set for eGFRmet (10.0%) was more accurate than eGFRcr (13.1%) and eGFRcys (12.0%) but not eGFRcr-cys (8.7%). Combining metabolites, creatinine, cystatin C, and demographics led to the most accurate equation (7.0%). Neither equation had substantial variation among population subgroups. CONCLUSIONS: The new eGFRmet equation could serve as a confirmatory test for GFR estimation.
BACKGROUND: Clinical practice guidelines recommend estimation of glomerular filtration rate (eGFR) using validated equations based on serum creatinine (eGFRcr), cystatin C (eGFRcys), or both (eGFRcr-cys). However, when compared with the measured GFR (mGFR), only eGFRcr-cys meets recommended performance standards. Our goal was to develop a more accurate eGFR method using a panel of metabolites without creatinine, cystatin C, or demographic variables. METHODS: An ultra-performance liquid chromatography-tandem mass spectrometry assay for acetylthreonine, phenylacetylglutamine, pseudouridine, and tryptophan was developed, and a 20-day, multiinstrument analytical validation was conducted. The assay was tested in 2424 participants with mGFR data from 4 independent research studies. A new GFR equation (eGFRmet) was developed in a random subset (n = 1615) and evaluated in the remaining participants (n = 809). Performance was assessed as the frequency of large errors [estimates that differed from mGFR by at least 30% (1 - P30); goal <10%]. RESULTS: The assay had a mean imprecision (≤10% intraassay, ≤6.9% interassay), linearity over the quantitative range (r 2 > 0.98), and analyte recovery (98.5%-113%). There was no carryover, no interferences observed, and analyte stability was established. In addition, 1 - P30 in the validation set for eGFRmet (10.0%) was more accurate than eGFRcr (13.1%) and eGFRcys (12.0%) but not eGFRcr-cys (8.7%). Combining metabolites, creatinine, cystatin C, and demographics led to the most accurate equation (7.0%). Neither equation had substantial variation among population subgroups. CONCLUSIONS: The new eGFRmet equation could serve as a confirmatory test for GFR estimation.
Authors: Anna Solini; Maria Laura Manca; Giuseppe Penno; Giuseppe Pugliese; Jeff E Cobb; Ele Ferrannini Journal: J Clin Endocrinol Metab Date: 2015-12-18 Impact factor: 5.958
Authors: Anders Grubb; Masaru Horio; Lars-Olof Hansson; Jonas Björk; Ulf Nyman; Mats Flodin; Anders Larsson; Arend Bökenkamp; Yoshinari Yasuda; Hester Blufpand; Veronica Lindström; Ingrid Zegers; Harald Althaus; Søren Blirup-Jensen; Yoshi Itoh; Per Sjöström; Gunnar Nordin; Anders Christensson; Horst Klima; Kathrin Sunde; Per Hjort-Christensen; David Armbruster; Carlo Ferrero Journal: Clin Chem Date: 2014-05-14 Impact factor: 8.327
Authors: Elke S Schaeffner; Natalie Ebert; Pierre Delanaye; Ulrich Frei; Jens Gaedeke; Olga Jakob; Martin K Kuhlmann; Mirjam Schuchardt; Markus Tölle; Reinhard Ziebig; Markus van der Giet; Peter Martus Journal: Ann Intern Med Date: 2012-10-02 Impact factor: 25.391
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: John H Eckfeldt; Amy B Karger; W Greg Miller; Gregory P Rynders; Lesley A Inker Journal: Arch Pathol Lab Med Date: 2015-04-17 Impact factor: 5.534
Authors: Arlene B Chapman; Lisa M Guay-Woodford; Jared J Grantham; Vicente E Torres; Kyongtae T Bae; Deborah A Baumgarten; Philip J Kenney; Bernard F King; James F Glockner; Louis H Wetzel; Marijn E Brummer; W Charles O'Neill; Michelle L Robbin; William M Bennett; Saulo Klahr; Gladys H Hirschman; Paul L Kimmel; Paul A Thompson; J Philip Miller Journal: Kidney Int Date: 2003-09 Impact factor: 10.612
Authors: Hans Pottel; Liesbeth Hoste; Laurence Dubourg; Natalie Ebert; Elke Schaeffner; Bjørn Odvar Eriksen; Toralf Melsom; Edmund J Lamb; Andrew D Rule; Stephen T Turner; Richard J Glassock; Vandréa De Souza; Luciano Selistre; Christophe Mariat; Frank Martens; Pierre Delanaye Journal: Nephrol Dial Transplant Date: 2016-02-29 Impact factor: 5.992
Authors: Magdalena A Machnicka; Kaja Milanowska; Okan Osman Oglou; Elzbieta Purta; Malgorzata Kurkowska; Anna Olchowik; Witold Januszewski; Sebastian Kalinowski; Stanislaw Dunin-Horkawicz; Kristian M Rother; Mark Helm; Janusz M Bujnicki; Henri Grosjean Journal: Nucleic Acids Res Date: 2012-10-30 Impact factor: 16.971
Authors: Markus Fuhrmann; Amauri Schwaeble Santamaria; Renee Scott; Jeffrey W Meeusen; Marianna Fernandes; John Venz; Victoria Rothe; Frank Stämmler; Jochen Ehrich; Eric Schiffer Journal: Diagnostics (Basel) Date: 2022-04-30
Authors: Andrew S Levey; Silvia M Titan; Neil R Powe; Josef Coresh; Lesley A Inker Journal: Clin J Am Soc Nephrol Date: 2020-05-11 Impact factor: 8.237
Authors: Nan Chen; Hao Shi; Luxia Zhang; Li Zuo; Jingyuan Xie; Danshu Xie; Amy B Karger; Shiyuan Miao; Hong Ren; Wen Zhang; Weiming Wang; Yujing Pan; Wei Minji; Zhun Sui; Aghogho Okparavero; Andrew Simon; Juhi Chaudhari; John H Eckfeldt; Lesley A Inker; Andrew S Levey Journal: Kidney Med Date: 2020-01-31